Nomads Neutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
About Nomads Neutraceuticals
Nomads Neutraceuticals Private Limited (NNPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 12 January 2017 (Eight years and one month 13 days old ). Its registered office is in Noida, Uttar Pradesh.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ishan Sinha and Papia Bera serve as directors at the Company.
Company Details
- Location Noida, Uttar Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U15490UP2017PTC089083
- Company No.
089083
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2017
- Date of AGM
16 Sep 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
What products or services does Nomads Neutraceuticals Private Limited offer?
Nomads Neutraceuticals Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Spices Extracts, Plant Extracts, Root and Vegetable Extracts.
Who are the key members and board of directors at Nomads Neutraceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Papia Bera  | Director | 12-Jan-2017 | Current |
| Ishan Sinha | Director | 12-Jan-2017 | Current |
Financial Performance of Nomads Neutraceuticals.
Enhance accessibility to Nomads Neutraceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nomads Neutraceuticals?
Unlock access to Nomads Neutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nomads Neutraceuticals?
Unlock and access historical data on people associated with Nomads Neutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nomads Neutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nomads Neutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.